AMNEAL PHARMACEUTICALS, INC.
AMRX Healthcare Drug Manufacturers Specialty & Generic
AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024. In the quarter to June 2026, revenue grew 9.89%, EPS grew 157.1%, free cash flow fell 351.4% and total debt rose 8.22%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow AMRX
AMNEAL PHARMACEUTICALS, INC. (AMRX) P/E ratio
As of 16 October 2026, AMNEAL PHARMACEUTICALS, INC. (AMRX) trades at a P/E ratio of 38.4×. Over the past ten years it has ranged from 0.0× (June 2025) to 1,009× (September 2025); the current reading is higher than 78% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 19.2× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 54.8× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 69.2× | 703.82% |
| FY2020 | 8.6× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 34.6× | 8.62% |
| Mar 2026 | 31.9× | (41.82%) |
| Dec 2025 | 54.8× | (89.05%) |
| Sep 2025 | 501× | (38.13%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AMLX Amylyx Pharmaceuticals, Inc. compare | n/m |
| HIMS Hims & Hers Health, Inc. compare | n/m |
| RGC Regencell Bioscience Holdings Limited compare | n/m |
| INDV Indivior Pharmaceuticals Inc. compare | 11.2× |
| LNTH Lantheus Holdings, Inc. compare | 23.7× |
| RDY Dr. Reddy's Laboratories Ltd compare | 32.9× |
| AMRX AMNEAL PHARMACEUTICALS, INC. | 38.4× |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 73.4× |
| ALKS Alkermes plc compare | 102× |
| Drug Manufacturers Specialty & Generic industry median | 19.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)